Keywords: sprycel, gets, expedited, approval, cml, drug, major

Sprycel gets expedited approval for CML

Article | 10 July 2006

Print This

US drug major Bristol-Myers Squibb says that the Food and Drug Administration has granted accelerated approval for Sprycel (dasatinib), the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in